The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study

被引:57
|
作者
Wanders, Johanna O. P. [1 ]
Holland, Katharina [2 ]
Karssemeijer, Nico [2 ]
Peeters, Petra H. M. [1 ,3 ]
Veldhuis, Wouter B. [4 ]
Mann, Ritse M. [2 ]
van Gils, Carla H. [1 ]
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 855003508 GA, Utrecht, Netherlands
[2] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands
[3] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC,PHE Ctr Environm & Hlth, St Marys Campus,Norfolk Pl, London W2 1PG, England
[4] Univ Med Ctr Utrecht, Dept Radiol, POB 855003508 GA, Utrecht, Netherlands
来源
BREAST CANCER RESEARCH | 2017年 / 19卷
关键词
Volumetric mammographic breast density; Mammography screening; Interval breast cancer risk; MAMMOGRAPHIC DENSITY; TUMOR CHARACTERISTICS; VISUAL ASSESSMENT; CATEGORIES; POSTMENOPAUSAL; WOMEN; RADIOLOGISTS; MARKERS; TISSUE; MODE;
D O I
10.1186/s13058-017-0859-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In the light of the breast density legislation in the USA, it is important to know a woman's breast cancer risk, but particularly her risk of a tumor that is not detected through mammographic screening (interval cancer). Therefore, we examined the associations of automatically measured volumetric breast density with screen-detected and interval cancer risk, separately. Methods: Volumetric breast measures were assessed automatically using Volpara version 1.5.0 (Matakina, New Zealand) for the first available digital mammography (DM) examination of 52,814 women (age 50 - 75 years) participating in the Dutch biennial breast cancer screening program between 2003 and 2011. Breast cancer information was obtained from the screening registration system and through linkage with the Netherlands Cancer Registry. We excluded all screen-detected breast cancers diagnosed as a result of the first digital screening examination. During a median follow-up period of 4.2 (IQR 2.0-6.2) years, 523 women were diagnosed with breast cancer of which 299 were screen-detected and 224 were interval breast cancers. The associations between volumetric breast measures and breast cancer risk were determined using Cox proportional hazards analyses. Results: Percentage dense volume was found to be positively associated with both interval and screen-detected breast cancers (hazard ratio (HR) 8.37 (95% CI 4.34-16.17) and HR 1.39 (95% CI 0.82-2.36), respectively, for Volpara density grade category (VDG) 4 compared to VDG1 (p for heterogeneity < 0.001)). Dense volume (DV) was also found to be positively associated with both interval and screen-detected breast cancers (HR 4.92 (95% CI 2.98-8.12) and HR 2.30 (95% CI 1.39-3.80), respectively, for VDG-like category (C) 4 compared to C1 (p for heterogeneity = 0.041)). The association between percentage dense volume categories and interval breast cancer risk (HR 8.37) was not significantly stronger than the association between absolute dense volume categories and interval breast cancer risk (HR 4.92). Conclusions: Our results suggest that both absolute dense volume and percentage dense volume are strong markers of breast cancer risk, but that they are even stronger markers for predicting the occurrence of tumors that are not detected during mammography breast cancer screening.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds
    Tuong L. Nguyen
    Ye K. Aung
    Shuai Li
    Nhut Ho Trinh
    Christopher F. Evans
    Laura Baglietto
    Kavitha Krishnan
    Gillian S. Dite
    Jennifer Stone
    Dallas R. English
    Yun-Mi Song
    Joohon Sung
    Mark A. Jenkins
    Melissa C. Southey
    Graham G. Giles
    John L. Hopper
    [J]. Breast Cancer Research, 20
  • [32] Should screen-detected breast cancers be managed differently?
    Krzyzanowska, MK
    Tannock, IF
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (16) : 1170 - 1171
  • [33] Risk Factors for Second Screen-Detected or Interval Breast Cancers in Women with a Personal History of Breast Cancer Participating in Mammography Screening
    Houssami, Nehmat
    Abraham, Linn A.
    Kerlikowske, Karla
    Buist, Diana S. M.
    Irwig, Les
    Lee, Janie
    Miglioretti, Diana L.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (05) : 946 - 961
  • [34] Prognosis of small screen-detected invasive breast cancers
    Ellis, I.
    [J]. BREAST CANCER RESEARCH, 2008, 10 (Suppl 3)
  • [35] Prognosis of small screen-detected invasive breast cancers
    I Ellis
    [J]. Breast Cancer Research, 10
  • [36] Tumor characteristics in screen-detected and symptomatic breast cancers
    Palka, Istvan
    Kelemen, Gyoengyi
    Ormandi, Katalin
    Lazar, Gyoergy
    Nyari, Tibor
    Thurzo, Laszlo
    Kahan, Zsuzsanna
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2008, 14 (02) : 161 - 167
  • [37] An analysis of factors associated with interval as opposed to screen-detected breast cancers, including hormone therapy and mammographic density
    Crane, CEB
    Luke, CG
    Rogers, JM
    Playford, PE
    Roder, DM
    [J]. BREAST, 2002, 11 (02): : 131 - 136
  • [38] Prognosis of screen-detected breast cancers: results of a population based study
    Laura Cortesi
    Vincenzo E Chiuri
    Silvia Ruscelli
    Valeria Bellelli
    Rossella Negri
    Ivan Rashid
    Claudia Cirilli
    Antonella Fracca
    Ennio Gallo
    Massimo Federico
    [J]. BMC Cancer, 6
  • [39] Prognosis of screen-detected breast cancers: results of a population based study
    Cortesi, L
    Chiuri, VE
    Ruscelli, S
    Bellelli, V
    Negri, R
    Rashid, I
    Cirilli, C
    Fracca, A
    Gallo, E
    Federico, M
    [J]. BMC CANCER, 2006, 6 (1)
  • [40] Differences between screen-detected and interval breast cancers among BRCA mutation carriers
    Melissa Pilewskie
    Emily C. Zabor
    Elizabeth Gilbert
    Michelle Stempel
    Oriana Petruolo
    Debra Mangino
    Mark Robson
    Maxine S. Jochelson
    [J]. Breast Cancer Research and Treatment, 2019, 175 : 141 - 148